Clinical trial
Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer
NCT01347788
Study timeline
Study start (unknown)2011-04-01Date precision: month
Registry last updated2016-11-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Adenocarcinomaunresolved
Interventions
cabozantinibDRUG · verified · RxNorm: cabozantinib
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01347788 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.